Procter & Gamble Health Sees 45% Jump in Q1 Net Profit

Procter & Gamble Health Limited reported a significant year-on-year increase in standalone net profit for the quarter ended June 30, 2026, with ₹96.2 crore representing a growth of ≈45.32% YoY from ₹66.2 crore in the same period last fiscal year.

The strong performance highlights sustained demand for its key brands in the vitamins, minerals, and supplements sector, building upon its robust FY26 earnings.

Market analysts attribute this success to science-backed innovations and go-to-market strategies that have helped maintain market leadership and premium pricing power.